Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
Haematologica|May 29, 2025
CAR T expansion and systemic inflammation: diverging impacts on large B-cell lymphoma therapy in the multicenter CART SIE studyMartina Magni, Sadhana Jonnalagadda, Francesca Bonifazi, et al.
Annals of Hematology|March 28, 2021
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter studySalvatore Leotta, Uros Markovic, Maria Cristina Pirosa, et al.
Blood Advances|May 5, 2026
Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE studyGiulia Gabrielli, Beatrice Casadei, Annalisa Chiappella, et al.
Bone Marrow Transplantation|June 25, 2022
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMTRaynier Devillier, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Bone Marrow Transplantation|June 24, 2026
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first complete remissionDaniele Avenoso, Vera Radici, Alessandro Leoni, et al.
Transplantation and Cellular Therapy|November 6, 2024
Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic TransplantationChiara Nozzoli, Martina Pucillo, Luisa Giaccone, et al.
Bone Marrow Transplantation|January 22, 2024
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMaría Queralt Salas, Diderik-Jan Eikema, Linda Koster, et al.
Open Forum Infectious Diseases|May 5, 2025
The Changing Impact of Human Cytomegalovirus Serology and Infection on Patient Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey in the Era of Letermovir ProphylaxisCorrado Girmenia, Patrizia Chiusolo, Giovanni Marsili, et al.
Transplantation and Cellular Therapy|January 27, 2025
Prospective Validation of CAR-HEMATOTOX and a Simplified Version Predict Survival in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 CAR T-Cells: Data from CART-SIE StudyFederico Stella, Martina Pennisi, Annalisa Chiappella, et al.
Transplantation and Cellular Therapy|February 25, 2026
Systemic inflammation and CAR-T specific toxicities as major drivers of non-relapse mortality: analysis from the Italian prospective observational CART-SIE StudyAngelica Barone, Federico Stella, Silva Ljevar, et al.
Pageof 17